ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,545, issued on Aug. 12, was assigned to Allergan Pharmaceuticals International Ltd. (Dublin).
"Treatment of migraine" was invented by Joel M. Trugman (Hoboken, N.J.) and Michelle Finnegan (Madison, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof."
The patent was filed on March 27, 2025, under Application No. 19/092,662.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bo...